Background Although fear of cancer recurrence (FCR) or disease progression is among the
most endorsed unmet needs and concerns of cancer survivors, research on the course of …

Purpose: Some patients with long postoperative intervals of undetectable prostate specific
antigen are still at risk for biochemical recurrence. Our aims were to identify prognostic …

Objectives To investigate prevalence, course, and predictors of longitudinal decision regret
in long‐term prostate cancer (PCa) survivors treated by radical prostatectomy (RP). Patients …

It has been suggested that chromosome 7q32 contains genes that influence the progression
of prostate cancer from latent to invasive disease. In an attempt to confirm this linkage to …

Purpose The safety of active surveillance (AS) in favorable intermediate-risk (FIR) prostate
cancer (PCa) remains uncertain. To provide guidance on clinical decision-making, we …

Prostate cancer is a complex disease with a substantial genetic contribution involved in the
disease risk. Several genomewide linkage studies conducted so far have demonstrated a …

Abstract The International Consortium for Prostate Cancer Genetics (ICPCG) is an
international collaborative effort to pool pedigrees with hereditary prostate cancer (PC) in …

Purpose To assess whether a first-degree family history or a fatal family history of prostate
cancer (PCa) are associated with postoperative upgrading and upstaging among men with …

Purpose The objective of the current study was to assess whether and how preoperative risk
group distribution and pathological outcomes have changed in men treated with radical …

Purpose Overall 1 in 5 patients with prostate cancer has a positive family history. In this
report we evaluated the association between family history and long-term outcomes …